EUVIMEDEUVIMED entdecken
Crossref

Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats

Fangmei Luo, Minyi Fu, Ting Wang, Yanan Qi, Xuefeng Zhong, Dai Li, Bin Liu

Archives of Biochemistry and Biophysics · 2023-10 · 747 · 109743

DOI: 10.1016/j.abb.2023.109743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Biochemistry and Biophysics, 2023-10. Verfasst von Fangmei Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Hunan Children's Hospital, Changsha, 410007, China. Hauptthemen laut MEDLINE: Hypertension, Pulmonary. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation, Natural Science Foundation of Hunan Province, Fundamental Research Funds for Central Universities of the Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Maladaptive right ventricular (RV) remodeling is the most important pathological feature of pulmonary hypertension (PH), involving processes such as myocardial hypertrophy and fibrosis. A growing number of studies have shown that mitochondria-associated endoplasmic reticulum membranes (MAMs) are involved in various physiological and pathological processes, such as calcium homeostasis, lipid metabolism, inflammatory response, mitochondrial dynamics, and autophagy/mitophagy. The abnormal expression of MAMs-related factors is closely related to the occurrence and development of heart-related diseases. However, the role of MAM-related factors in the maladaptive RV remodeling of PH rats remains unclear. METHODS AND RESULTS: We first obtained the transcriptome data of RV tissues from PH rats induced by Su5416 combined with hypoxia treatment (SuHx) from the Gene Expression Omnibus (GEO) database. The results showed that two MAMs-related genes (Opa1 and Mfn2) were significantly down-regulated in RV tissues of SuHx rats, accompanied by significant up-regulation of cardiac hypertrophy-related genes (such as Nppb and Myh7). Subsequently, using the SuHx-induced PH rat model, we found that the downregulation of mitochondrial fusion proteins Opa1 and Mfn2 may be involved in maladaptive RV remodeling by accelerating mitochondrial dysfunction. Finally, at the cellular level, we found that overexpression of Opa1 and Mfn2 could inhibit hypoxia-induced mitochondrial fission and reduce ROS production in H9c2 cardiomyocytes, thereby retarded the progression of cardiomyocyte hypertrophy. CONCLUSIONS: The down-regulation of mitochondrial fusion protein Opa1/Mfn2 can accelerate cardiomyocyte hypertrophy and then participate in maladaptive RV remodeling in SuHx-induced PH rats, which may be potential targets for preventing maladaptive RV remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypertension, PulmonaryRatsAnimalsMyocytes, CardiacMitochondrial DynamicsDown-RegulationMitochondrial ProteinsMitochondriaHydrolasesHypoxiaHypertrophyVentricular RemodelingGTP Phosphohydrolases

Stichwörter der Autor:innen

Maladaptive right ventricular remodelingMitochondria-associated endoplasmic reticulum membranesMitochondrial dynamicsMitofusin 2Optic atrophy 1Pulmonary hypertension

Substanzen

Mitochondrial ProteinsHydrolasesOpa1 protein, ratGTP Phosphohydrolases

Autor:innen und Institutionen

  • Department of Pharmacy, Hunan Children's Hospital, Changsha, 410007, China.
  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China; Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospi…
  • Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, 410008, China.
  • Phase Ⅰ Clinical Trial Center, Xiangya Hospital, Central South University, Changsha, 410008, China.

Förderung

  • China Postdoctoral Science Foundation
  • Natural Science Foundation of Hunan Province
  • Fundamental Research Funds for Central Universities of the Central South University
  • Natural Science Foundation of Changzhou Municipality
  • National Natural Science Foundation of China
  • Health Commission of Hunan Province

Zitieren

APA

Luo, F., Fu, M., Wang, T., Qi, Y., Zhong, X., Li, D., & Liu, B. (2023). Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats. Archives of Biochemistry and Biophysics, 747, 109743. https://doi.org/10.1016/j.abb.2023.109743

Vancouver

Luo F, Fu M, Wang T, Qi Y, Zhong X, Li D, et al. Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats. Archives of Biochemistry and Biophysics. 2023;747:109743. doi:10.1016/j.abb.2023.109743

BibTeX
@article{Luo2023,
  author = {Luo, Fangmei and Fu, Minyi and Wang, Ting and Qi, Yanan and Zhong, Xuefeng and Li, Dai and Liu, Bin},
  title = {Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats},
  journal = {Archives of Biochemistry and Biophysics},
  year = {2023},
  volume = {747},
  pages = {109743},
  doi = {10.1016/j.abb.2023.109743}
}
Kostenlos starten →